Scroll To Top
Search by Speciality

17th Annual European Congress of Rheumatology

ExCeL London * | London, UK
From 150 to 780 GBP
Event Preview
EXPIRED
This event
is Finished
Title: 17th Annual European Congress of Rheumatology
Specialty: Rheumatology
Dates: From Jun, 8, 2016 to Jun, 11, 2016
Location: London, UK
Type: Congress
Registration Cost: From 150 to 780 GBP
Event Tools
  • Add to Favorites
  • Claim this event
Add to my Calendar
  • Scientific Programm
  • Online registration
  • Exhibition floorplans
  • Sponsorship &
    Exhibition consensus
  • Virtual Booths
Jun
Weather Info (monthly averages) Max Temperature: C / F Min Temperature: C / F The above data in our Weather Info table are temperature predictions for the date of the medical event for London, Uk.
General Info
Event Venue:

ExCeL London *

London, UK Visit the Venue to read more
Currency:
GBP
Concerned Audience:
  • Medical_Professionals
  • Medical_students
  • Nurses
Event Overview
Welcome message:

Dear Colleagues,

The next EULAR Annual European Congress of Rheumatology will take place between the 8 and 11 June 2016 in London. The annual EULAR congresses which began in 2000 are today a major event in the calendar of world rheumatology. The meeting will again provide a unique occasion for the exchange of scientific and clinical information. It should facilitate interaction between patients, medical doctors, scientists, health professionals and professionals representing the pharmaceutical industry both from Europe and from around the world. You are certainly aware that participating in the congress is just one element of the annual educational package provided by EULAR. Thus in addition, the participants will have the opportunity to watch virtually all oral presentations through electronic capture and will be provided with a complimentary one-year access to the newest developments and publications in the field of RMDs.

EULAR has grown rapidly in terms of the number of participants and the quality of the submissions. Thus, more than 4,300 abstracts were submitted to the most recent congress in Rome and more than 195 sessions and poster tours were offered. This enormous success reflects the ever increasing interest in rheumatic and musculoskeletal diseases (RMDs) which has been seen in most societies and is now recognized also by the EU. It also reflects the availability of increased information on the size, burden and cost of these diseases for society, and a significantly improved ability to diagnose and treat them. The incorporation of health professional and patient organisations within EULAR has been a considerable stimulus for these advances.  

The EULAR Congress 2016 in London will once again provide a wide range of topics including clinical innovations, clinical translational and basic science. In addition there will be significant contributions made by People with Arthritis and Rheumatism (PARE), by Health Professionals in Rheumatology (HPR) and by the health care industry. The core science and central activity of the congress will be the poster presentations and poster tours with their highly interactive exchanges between participants. The London meeting will further promote the reputation of the EULAR Congress as a most innovative and informative venue for clinical research for the practising physician. The EULAR EMEUNET organisation of young rheumatologists also hopes to attract young colleagues to the meeting and will disseminate the message that rheumatology is one of the most attractive and successful disciplines of medicine.

The city of London needs little introduction. "Tired of London, tired of life" is a quotation previously used for the 2011 EULAR congress in London, and it is even more reinforced by the recent accolade of "world city", and indicates how ideal a venue this is for an international meeting such as the EULAR Congress which has truly become a world congress. The elegance of London with its architecture, galleries, theatres and ambience should again provide an excellent background for clinical exchanges, international collaborations and renewal of friendships. It is our great pleasure and a real joy in welcoming medical doctors, patients, health professionals and representatives of the pharmaceutical industry and hope their stay in London will be delightful, informative and educational.

Gerd R. Burmester

President of EULAR

Registration Needs updating Register Now
Currency:

GBP

Registration Cost
Type
Early Registration

2016-01-31
Late Registration From: 2016-02-01 To: 2016-05-19
On site Registration
Full Delegate
590
650
780
HPR delegate
150
180
210
PARE delegate
150
180
210
Trainee
230
240
270

Group Registrations:

Group registrations not allowed

Accompanying Persons:

Accompanying persons not allowed

Registration Documents:
Letter of invitation:
We don’t provide letter of invitation
Letter of confirmation:
We don’t provide Letter of Confirmation
Proof of professional / educational status:
We don’t need Proof of professional/educational status
Online Abstract Submission:

We don’t accept Online Abstracts

Accommodation
Accommodation:

ExCeL Exhibition Centre   

One Western Gateway, Royal Victoria Dock London United Kingdom

Scientific Content Up to Date
Submission Info

Abstracts can only be submitted online via the online abstract submission system. Abstracts sent by post or email will not be accepted. No exceptions will be made.

Technical requirements

The internet abstract submission system works best with Internet Explorer 7.0 or higher and Mozilla Firefox 3.0 or higher. Cookies and JavaScript need to be enabled.

Abstract submission must be in one of the three different categories:

a. Medical or Research Professional / Clinician

b. Health Professional in Rheumatology / Practice and Research

c. PARE Member / Patient


The categories are subdivided into topics (Abstract topics).

The correct category and topic must be selected to ensure correct scoring.

The content of the abstract must be topic related.

 

Please read all instructions carefully before preparing your

abstract.

 

For standardisation, the acceptable length of the abstract is not more than 3600 characters and 55 lines, authors’ details and headers included. This also includes non-visible characters such as spaces as well as punctuation.

 

The abstract should be structured into the following sections:

a. A title which clearly indicates the nature of the investigation

b. Background

c. Objectives

d. Methods

e. Results

f. Conclusions

g. References

 

One graph/image can be included with the following criteria :

Image width : min. 50 pixels - max. 750 pixels

Image height : min. 50 pixels - max. 750 pixels

Image quality : min. 96 dpi - max. 300 dpi

Image file size : min. 35 KB - max. 1000 KB

Allowed file type : gif, jpg

 

Abstracts can be saved in “Draft” status to be re-edited and modified until the submission deadline (31 January 2016, 23:59 CET). Therefore, the submitter will be required to create a user account.

 

Abstracts fulfilling all criteria can be saved in “Final submission” status. Only a stracts in “Final submission” status will be regarded as successfully submitted and considered for the congress. Abstracts in “Final submission” status can be re-edited and modified until the submission deadline (31 January 2016, 23:59 CET).

 

An abstract can only be submitted if the “Rules and Regulations, including the

EULAR embargo rules” on the online abstract form are read and accepted.

 

Conflict of interest: It is the intent of EULAR to provide highquality sessions focused on educational content that is free from commercial influence or bias. Thus the submitting author of an abstract is requested to declare any potential conflicts of interest for all authors during the abstracts submission.

 

The inclusion of trade names/brand names is not allowed in the abstract. The mentioning of agents/molecules must follow the scientific standard for publications.

 

Abstracts accepted for the congress are subject to the “EULAR embargo rules” and the “Transfer of copyright” as published in the right column on this page. With the submission of an abstract the authors agree to the embargo

rules and the transfer of copyright.

 

The Corresponding Author has the right to grant, and does grant, on behalf of all authors an exclusive licence on a worldwide basis to the BMJ Publishing Group Ltd and EULAR to publish the abstract (if accepted) in any media and to exploit all subsidiary rights.

 

Should the abstract be selected for oral presentation, the authors, represented by the presenting author will have to sign an agreement to grant EULAR the right to record the presentation (audio and slide) and subsequently use it for educational purposes (with or without a fee). The full text of the agreement can be in the right column on this page.

 

Only abstracts that contain original data can be submitted.

 

Abstracts should not be submitted if the following applies:

a. the abstract contains data that has been published or accepted for publication in a print or online journal

b. the abstract contains data that was presented at a scientific meeting more than 12 months prior to EULAR 2016

 

Abstracts containing data that has been presented or will be presented at a different scientific meeting during a 12 months period prior to EULAR 2016 can be submitted. This fact must be indicated on the submission form.

 

Abstracts having been submitted for publication or to a scientific meeting, but are pending acceptance, can be submitted without restrictions. However, once the abstract has been accepted by EULAR it is automatically subject to the EULAR embargo rules.

 

The reviewers will judge the abstracts according to the scientific or clinical value, relevance to EULAR, suitability of methods to aims, conclusions confirmed by objective results, objectivity of statements, description of methods used, ethics, originality of work, standard of English and overall impression.

 

Splitting of data originating from the same study across several abstracts and/or topics is not permitted and will lead to rejection of the abstracts.

 

Please ensure that your abstract does not contain spelling, grammatical or scientific errors, as it will be reproduced exactly as submitted. No proofreading will be done.

 

Accepted abstracts will be published in a supplement to the Annals of Rheumatic Diseases. Information on accepted abstracts will also be available online on the on this web site about one month prior to the congress. Published abstracts will

be available in the EULAR abstract archive after the congress.

 

The submission of an abstract constitutes a formal commitment by the presenting author to present the abstract (if accepted) orally or as a poster in the session and the time assigned by the EULAR Scientific Committee. We therefore recommend that submitters of abstracts register for the congress simultaneously with the abstract submission.

 

Abstracts not adhering to these guidelines will be rejected. If you do not agree with any of these rules, you should not submit an abstract. The final decision about acceptance of an abstract will be taken by the EULAR Scientific Committee.

EULAR does not correspond on the reasons for acceptance/ rejection of an abstract.

 

If you need to withdraw your abstract, a written statement reflecting the reasons for this decision must be sent to the EULAR Secretariat or MCI not later than 1 April 2016.

Sponsors Exhibitors
General Info

EULAR Contact Information


Address


Seestrasse 240, CH-8802, Kilchberg, Switzerland


Phone: (41 44) 716 30 30

Fax: (41 44) 716 30 39

E-mail: eular@eular.org

Contact
Organising Agency

EULAR Contact Information


Address


Seestrasse 240, CH-8802, Kilchberg, Switzerland


Phone: (41 44) 716 30 30

Fax: (41 44) 716 30 39

E-mail: eular@eular.org

Official Event Webpage
Event map
Revelant Events